The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
ansuvimab · Injection, Powder, Lyophilized, For Solution
3 marketed package NDCs · 2 active manufacturers
What changed in the last 90 days
Every detected change for ansuvimab, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- EbangaAug 26, 2026Mfr exitedEmergent Manufacturing Operations Baltimore, LLC · ansuvimab
- EbangaAug 18, 2026Mfr enteredEmergent BioDefense Operations Lansing LLC · ansuvimab
- EbangaAug 18, 2026Product updatelabeler name: Emergent Manufacturing Operations Baltimore, LLC → Emergent BioDefense Operations Lansing LLC
- EbangaAug 18, 2026Product updatelabeler name: Emergent Manufacturing Operations Baltimore, LLC → Emergent BioDefense Operations Lansing LLC
- EbangaAug 18, 2026Product updatelabeler name: Emergent Manufacturing Operations Baltimore, LLC → Emergent BioDefense Operations Lansing LLC
- EbangaAug 12, 2026Mfr exitedRidgeback Biotherapeutics, LP · ansuvimab
Common questions
- Is Ansuvimab in shortage right now?
- No. FDA does not currently list Ansuvimab in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Ansuvimab?
- 2 companies have marketed Ansuvimab in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.